Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

stravencon ltd. - céfuroxime sodique - eq. céfuroxime 750 mg - poudre pour solution pour perfusion - 750 mg - céfuroxime sodique - cefuroxime

Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

stravencon ltd. - céfuroxime sodique - eq. céfuroxime 1500 mg - poudre pour solution injectable/pour perfusion - 1500 mg - céfuroxime sodique - cefuroxime

Israel - engelsk - Ministry of Health

vitamed ltd, israel - cefuroxime as sodium - powder for solution or suspension for injection or infusion - cefuroxime as sodium 750 mg - cefuroxime - cefuroxime – vit is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth):• community acquired pneumonia• acute exacerbations of chronic bronchitis• complicated urinary tract infections, including pyelonephritis• soft-tissue infections: cellulitis, erysipelas and wound infections• intra-abdominal infections• prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section)• nose infections for example, sinusitis• septic arthritis

Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

codal-synto limited (0000010484) 21 constantinoupoleos str., limassol, 3011, 51785 (3508) - cefuroxime sodium - powder for injection - 1.5g - cefuroxime sodium (0056238632) 1,5g base - cefuroxime

Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

codal-synto limited (0000010484) 21 constantinoupoleos str., limassol, 3011, 51785 (3508) - cefuroxime sodium - powder for injection - 750mg/vial - cefuroxime sodium (0056238632) 750mg base - cefuroxime

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

cristers - céfuroxime 250 mg sous forme de : céfuroxime axétil - comprimé - 250 mg - pour un comprimé > céfuroxime 250 mg sous forme de : céfuroxime axétil - antibiotiques antibacteriens de la famille des bêta-lactamines du groupe des céphalosporines de deuxième génération. - antibiotiques antibacteriens de la famille des bêta-lactamines du groupe des céphalosporines de deuxième génération.ce médicament est réservé à l'adulte et à l'enfant à partir de 6 ans.il est indiqué chez l'adulte : dans le traitement des otites aiguës, des sinusites, de certaines angines et pharyngites (angines récidivantes et/ou inflammation chroniques des amygdales), dans le traitement des infections respiratoires: bronchites aiguës et chroniques, pneumopathies bactériennes (présence de germes au niveau des poumons).il est indiqué chez l'enfant à partir de 6 ans : dans le traitement des otites aiguës, de certaines angines et pharyngites, dans le traitement des infections respiratoires.

Israel - engelsk - Ministry of Health

pharmalogic ltd - cefuroxime as sodium - powder for solution for inj/inf - cefuroxime as sodium 750 mg/vial - cefuroxime - cefuroxime - infections caused by susceptible microorganisms, prophylaxis against post operative infections in a variety of operations.

USA - engelsk - NLM (National Library of Medicine)

a-s medication solutions - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 250 mg - cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes. limitations of use - the efficacy of cefuroxime axetil in the prevention of rheumatic fever was not established in clinical trials. - the efficacy of cefuroxime axetil in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae , haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute bacte

USA - engelsk - NLM (National Library of Medicine)

a-s medication solutions - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 250 mg - cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes . limitations of use - the efficacy of cefuroxime axetil in the prevention of rheumatic fever was not established in clinical trials. -  the efficacy of cefuroxime axetil in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae, haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute ba

Malta - engelsk - Medicines Authority

dr. friedrich eberth arzneimittel gmbh am bahnhof 2, ursensollen 92289, germany - cefuroxime sodium - powder for solution for infusion or injection - cefuroxime sodium 750 mg - antibacterials for systemic use